C
Connecticut Eye Consultants, P.C. | Danbury, CT
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Zimura
EYP-1901
Satralizumab
Elamipretide
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Active, not recruiting
Wet Age Related Macular Degeneration
wAMD
Drug: Aflibercept (2.0 mg)
Drug: EYP-1901
The purpose of this study is to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of subcutaneous (SC) satralizumab, a recombinant,...
Active, not recruiting
Thyroid Eye Disease
Drug: Satralizumab
Drug: Placebo
The goal of this clinical trial is to evaluate the efficacy, safety and pharmacokinetics of elamipretide in subjects with dry age-related macular deg...
Enrolling
Age Related Macular Degeneration (ARMD)
Drug: Elamipretide
Drug: Placebo
Trial sponsors
E
I
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems